Mesenchymal stem cell therapy for acute and chronic pancreatitis

被引:29
|
作者
Kawakubo, Kazumichi [1 ,2 ]
Ohnishi, Shunsuke [1 ,2 ]
Kuwatani, Masaki [3 ]
Sakamoto, Naoya [1 ,2 ]
机构
[1] Hokkaido Univ, Fac Med, Dept Gastroenterol & Hepatol, Kita Ku, Kita15 Nishi7, Sapporo, Hokkaido 0608638, Japan
[2] Hokkaido Univ, Grad Sch Med, Kita Ku, Kita15 Nishi7, Sapporo, Hokkaido 0608638, Japan
[3] Hokkaido Univ Hosp, Div Endoscopy, Kita Ku, Kita14 Nishi5, Sapporo, Hokkaido 0608648, Japan
基金
日本学术振兴会;
关键词
Mesenchymal stem cells; Acute pancreatitis; Chronic pancreatitis; Regenerative medicine; Cell therapy; TRANSPLANTATION; RATS; MICE;
D O I
10.1007/s00535-017-1363-9
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Mesenchymal stem cells (MSCs) have attracted attention as a cell source for regenerative medicine. In particular, MSCs have an anti-inflammatory effect by secreting several kinds of bioactive molecules. MSC therapy is now being applied to various gastrointestinal diseases, such as graft-versus-host disease, inflammatory bowel disease, and liver cirrhosis. Therefore, MSC therapy has the potential to be a novel treatment for acute and chronic pancreatitis by suppressing inflammation. Several studies have investigated the effect of MSC therapy on acute and chronic pancreatitis, but the underlying mechanisms remain unknown. In this review, we summarize the present status of MSC therapy for acute and chronic pancreatitis.
引用
收藏
页码:1 / 5
页数:5
相关论文
共 50 条
  • [41] Stem cell therapy for acute myocardial infarction: Mesenchymal Stem Cells and induced Pluripotent Stem Cells
    Clavellina, Diana
    Balkan, Wayne
    Hare, Joshua M.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2023, 23 (10) : 951 - 967
  • [42] Mesenchymal stem cell therapy in skin: why and what for?
    Khosrotehrani, Kiarash
    EXPERIMENTAL DERMATOLOGY, 2013, 22 (05) : 307 - 310
  • [43] Mesenchymal Stem Cells and Cell Therapy for Bone Repair
    Wang, Shihua
    Xu, Pengchao
    Li, Xiaoxia
    Su, Xiaodong
    Chen, Yunfei
    Wan, Li
    Fan, Linyuan
    Yin, Kan
    Liu, Yan
    Zhao, Robert Chunhua
    CURRENT MOLECULAR PHARMACOLOGY, 2016, 9 (04) : 289 - 299
  • [44] Rationale of Mesenchymal Stem Cell Therapy in Kidney Injury
    Cantaluppi, Vincenzo
    Biancone, Luigi
    Quercia, Alessandro
    Deregibus, Maria Chiara
    Segoloni, Giuseppe
    Camussi, Giovanni
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2013, 61 (02) : 300 - 309
  • [45] Could extracellular vesicles derived from mesenchymal stem cells be a potential therapy for acute pancreatitis-induced cardiac injury?
    Pan, Long-Fei
    Niu, Ze-Qun
    Ren, Song
    Pei, Hong-Hong
    Gao, Yan-Xia
    Feng, Hui
    Sun, Jiang-Li
    Zhang, Zheng-Liang
    WORLD JOURNAL OF STEM CELLS, 2023, 15 (07): : 654 - 664
  • [46] Therapy With Mesenchymal Stem Cells in Parkinson Disease: History and Perspectives
    Mendes Filho, Daniel
    Ribeiro, Patricia D. C.
    Oliveira, Lucas F.
    de Paula, Diogenes R. M.
    Capuano, Vanessa
    de Assuncao, Thais S. F.
    da Silva, Valdo J. D.
    NEUROLOGIST, 2018, 23 (04) : 141 - 147
  • [47] Rationale of Mesenchymal Stem Cell Therapy in Kidney Injury
    Fleig, Susanne V.
    Humphreys, Benjamin D.
    NEPHRON CLINICAL PRACTICE, 2014, 127 (1-4): : 75 - 80
  • [48] Potential of mesenchymal stem cell therapy
    Dazzi, Francesco
    Horwood, Nicole J.
    CURRENT OPINION IN ONCOLOGY, 2007, 19 (06) : 650 - 655
  • [49] Effect of umbilical cord mesenchymal stem cells on treatment of severe acute pancreatitis in rats
    Yang, Bin
    Bai, Bin
    Liu, Chao-Xu
    Wang, Shi-Qi
    Jiang, Xue
    Zhu, Cai-Lin
    Zhao, Qing-Chuan
    CYTOTHERAPY, 2013, 15 (02) : 154 - 162
  • [50] Mesenchymal and mononuclear stem cell therapy for acute ischemic stroke - A systematic review
    Kurniawan, Mohammad
    Ramli, Yetty
    Ranakusuma, Teguh A. S.
    Harris, Salim
    Rasyid, Al
    Mesiano, Taufik
    Hidayat, Rakhmad
    NEUROLOGY ASIA, 2023, 28 (04) : 857 - 866